Zum Hauptinhalt springen

Adventures of CD8+ T-cells in the tumor microenvironment

Adventures of CD8+ T-cells in the tumor microenvironment

TRR 305 seminar series

31. Januar 2024

14.00 - 15.30 Uhr

hybrid (on site in Regensburg)

Seminarroom of the Chair of Experimental Medicine

CD8+ T-cells are essential for the immunological control of cancer but their fate in the tumor microenvironment depends on numerous variables, many of which are insufficiently known. Type I interferon is a central factor in the tumor environment and as such, orchestrates many processes. For example, it promotes cross-presentation of antigens to CD8+ T-cells and is essential for the clinical response to radiotherapy. Furthermore, so-called hot tumors - tumors that are heavily infiltrated by T-cells - are characterized by a type-I-interferon-signature. Type I interferons are downstream of the cGAS-STING pathway that is activated by cytoplasmic double-stranded DNA. In contrast to healthy cells, cancer cells contain high concentrations of cytoplasmic double-stranded DNA, which can be even further increased by genotoxic treatments such as radiotherapy. There is evidence that the cGAS-STING pathway promotes immune-mediated cancer restriction, although our new data suggest that T-cell intrinsic STING signaling compromizes their function. The seminar will address the apparent controversy related to STING signaling in the tumor microenvironment and will propose mechanisms of how genotoxic treatment can drive differentiation of tumor-resident CD8+ T-cells.

Linda Schadt, Colin Sparano, Nicole Angelika Schweiger, Karina Silina, Virginia Cecconi, Giulia Lucchiari, Hideo Yagita, Emilien Guggisberg, Sascha Saba, Zuzana Nascakova, Winfried Barchet, Maries van den Broek, Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity, Cell Reports, Volume 29, Issue 5, 2019, Pages 1236-1248.e7, ISSN 2211-1247, https://doi.org/10.1016/j.celrep.2019.09.065.

Tallón de Lara, P., Castañón, H., Vermeer, M. et al. CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer. Nat Commun 12, 769 (2021). https://doi.org/10.1038/s41467-021-21045-2


https://uni-regensburg.zoom x.de/meeting/register/u5UqdO6hqz0sHdA8H1NRCQZghTAxy4uUNGZN

Meeting-ID: 617 3795 6674

Kenncode: 219353